David T. Howton

Companies

• Solid Biosciences Inc.Chief operating officer Dec 5, 2023 to now¹
• Solid Biosciences Inc.Officer Dec 5, 2022 to Dec 5, 2022²
• Sarepta TherapeuticsGeneral counsel Nov 7, 2012 to Jun 22, 2020³
• Vertex PharmaceuticalsGeneral counsel Feb 6, 2012 to Feb 6, 2012⁴
• Vertex PharmaceuticalsSVP Sep 7, 2011 to Sep 7, 2011⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SBSolid Biosciences Inc. SLDB105,077 shares⁶$606.3K at $5.77Feb 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 18, 2026Sold 7,469 shares at $5.82 of Solid Biosciences Inc.⁶
• Feb 13, 2026Exercised options 14,687 shares of Solid Biosciences Inc.⁶
• Feb 4, 2026Sold 18,894 shares at $6.44 of Solid Biosciences Inc.⁷
• Feb 2, 2026Sold 37,771 shares at $6.44 of Solid Biosciences Inc.⁸
• Jan 31, 2026Exercised options 42,275 shares of Solid Biosciences Inc.⁸
• Jan 29, 2026Exercised options 79,341 shares of Solid Biosciences Inc.⁸
• Dec 3, 2025Sold 4,932 shares at $5.11 of Solid Biosciences Inc.⁹
• Dec 2, 2025Exercised options 13,051 shares of Solid Biosciences Inc.⁹
• Feb 14, 2025Sold 5,561 shares at $3.96 of Solid Biosciences Inc.¹⁰
• Feb 13, 2025Exercised options 14,687 shares of Solid Biosciences Inc.¹⁰
• Dec 3, 2024Sold 5,072 shares at $5.60 of Solid Biosciences Inc.¹¹
• Dec 2, 2024Exercised options 13,051 shares of Solid Biosciences Inc.¹¹
• Dec 4, 2023Sold 5,367 shares at $2.78 of Solid Biosciences Inc.¹²
• Dec 2, 2023Exercised options 13,051 shares of Solid Biosciences Inc.¹²